Atorvastatin inhibits atherogenesis by RXRα-mediated depressing oxidative stress in STZ-induced diabetic ApoE-/- mice with fat-rich diet
LIN Xiao-yan1, LIN Qiu-ping2, XU Chang-sheng3, NING Ruo-bing3, ZHU Jiang3, LIN Jin-xiu3, CHAI Da-jun3
1Ultrasound Imaging Division of the First Affiliated Hospital, Fujian Medical University, 2Fujian Provincial Cancer Hospital, 3Cardiovascular Department of the First Affiliated Hospital, Fujian Medical University, Fujian Hypertension Institute, Fuzhou 350005, China.
AIM: To explore the effects of atorvastatin (Atorv) on atherosclerosis in streptozotocin (STZ)-induced diabetic apolipoprotein E knockout (ApoE-/-) mice with fat-rich diet and the possible mechanism. METHODS：C57 mice served as control. ApoE-/- mice (n=34) fed with high-fat diet were randomly divided into ApoE-/- group, STZ-ApoE-/- group and STZ-ApoE-/-+Atorv group. Intraperitoneal injection of streptozotocin was performed to create diabetic animal model. Blood glucose was determined by glucose oxidase method. Blood lipid levels were detected by enzymic method or selective homogeneous method. The plaque area in the thoracic aorta was measured by HE staining. The protein level of nicotinamide-adenine dinucleotide phosphate (NADPH) oxidase subunit gp91phox in the thoracic aorta was determined by Western blotting. The levels of reactive oxygen species (ROS) in blood and thoracic aorta homogenates were detected by Fenton reaction and Griess reagent. Human umbilical vein endothelial cells (HUVECs) were isolated from healthy umbilical cords by collagenase I and cultured. ROS production was detected by flow cytometry. NADPH oxidase activity was measured using lucigenin assay.Effects of retinoid X receptor α (RXRα) on inhibition of oxidative stress by atorvastatin were evaluated by RNA interference and plasmid transfection. RESULTS：(1) Compared with C57 group, the plaque areas of the thoracic aorta in ApoE-/- group were increased. No difference of the fasting glucose between the 2 groups was observed. The levels of triglyceride (TG), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), thoracic aorta gp91phox protein and ROS in blood and thoracic aorta homogenates were higher in ApoE-/- group than those in C57 group. (2) Compared with ApoE-/- group, the plaque areas of the thoracic aorta in STZ-ApoE-/- group were further enlarged ［(314.13±35.72) μm2 vs (215.88±34.19) μm2, P<0.05］. The levels of blood glucose, TG, TC and LDL-C, thoracic aorta gp91phox protein and ROS in blood and thoracic aorta homogenates were higher in STZ-ApoE-/- group than those in ApoE-/- group (P<0.05). (3) Compared with STZ-ApoE-/- group, the plaque areas of the thoracic aorta in STZ-ApoE-/- +Atorv group were reduced ［(217.47±24.56） μm2 vs （314.13±35.72） μm2, P<0.05］. The levels of blood glucose, LDL-C, TC, HDL-C and TG showed no significant difference between the 2 groups. Thoracic aorta gp91phox protein level and ROS production in blood and thoracic aorta homogenates were lower in STZ-ApoE-/- +Atorv group than those in STZ-ApoE-/- group (P<0.05). (4) High glucose-induced increases in NADPH oxidase activity and gp91phox expression were significantly inhibited by atorvastatin (10-6 mol/L) in HUVECs. The inhibitory effects of atorvastatin on high glucose-induced ROS production and NADPH oxidase activation were largely impaired when the cells were transfected with RXRα siRNA. However, the effect of atorvastatin was significantly strengthened when RXRα was over-expressed in the HUVECs transfected with RXRα plasmid. CONCLUSION：Atorvastatin inhibits atherogenesis by depressing high glucose-induced oxidative stress in diabetic ApoE-/- mice with fat-rich diet. The anti-oxidative stress effect of atorvastatin is mediated by RXRα.
Sharrett AR, Ballantyne CM, Coady SA, et al. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: the Atherosclerosis Risk in Communities (ARIC) study［J］. Circulation, 2001,104(10):1108-1113.
［3］
Selvaraju V, Joshi M, Suresh S, et al. Diabetes, oxidative stress, molecular mechanism, and cardiovascular disease: an overview［J］. Toxicol Mech Methods, 2012, 22(5):330-335.
［4］
Matsumoto T, Kobayashi T, Wachi H, et al. Vascular NAD(P)H oxidase mediates endothelial dysfunction in basilar arteries from Otsuka Long-Evans Tokushima Fatty (OLETF) rats［J］. Atherosclerosis, 2007, 192(1):15-24.
［5］
Ding H, Aljofan M, Triggle CR. Oxidative stress and increased eNOS and NADPH oxidase expression in mouse microvessel endothelial cells［J］. J Cell Physiol, 2007, 212(3):682-689.
［6］
Nichols GA, Vupputuri S, Rosales AG. Change in high-density lipoprotein cholesterol and risk of subsequent hospitalization for coronary artery disease or stroke among patients with type 2 diabetes mellitus［J］. Am J Cardiol, 2011, 108(8):1124-1128.
Lalloyer F, Fiévet C, Lestavel S, et al. The RXR agonist bexarotene improves cholesterol homeostasis and inhibits atherosclerosis progression in a mouse model of mixed dyslipidemia［J］. Arterioscler Thromb Vasc Biol, 2006, 26（12）:2731-2737.
［9］
Chai D, Wang B, Shen L, et al. RXR agonists inhibit high-glucose-induced oxidative stress by repressing PKC activity in human endothelial cells［J］. Free Radic Biol Med, 2008, 44(7): 1334-1347.
［10］
Jaffe EA, Nochman RL, Becker CG, et al. Culture of human endothelial cells from umbilical veins: identification by morphologic and immunologic criteria［J］. J Clin Invest, 1973, 52(11): 2745-2758.
［11］
Shen GX. Oxidative stress and diabetic cardiovascular disorders: roles of mitochondria and NADPH oxidase［J］. Can J Physiol Pharmacol, 2010, 88(3):241-248.
［12］
Mudau M, Genis A, Lochner A, et al. Endothelial dysfunction: the early predictor of atherosclerosis［J］. Cardiovasc J Afr, 2012, 23(4):222-231.
［13］
Choi BJ, Prasad A, Gulati R, et al. Coronary endothelial dysfunction in patients with early coronary artery disease is associated with the increase in intravascular lipid core plaque［J］. Eur Heart J, 2013, 34(27):2047-2054.
［14］
Jiang F, Qian J, Chen S, et al. Ligustrazine improves atherosclerosis in rat via attenuation of oxidative stress［J］. Pharm Biol, 2011, 49(8):856-863.
［15］
Cui W, Matsuno K, Iwata K, et al. NADPH oxidase isoforms and anti-hypertensive effects of atorvastatin demonstrated in two animal models［J］. J Pharmacol Sci, 2009, 111(3):260-268.
